Press release
Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11.06 Billion Opportunity
Pleural Diseases Therapeutics Market
Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16576
Quick Stats Snapshot
• Market Size (2025): USD 5.65 billion
• Estimated Value (2026): USD 6.00 billion
• Forecast (2036): USD 11.06 billion
• CAGR (2026-2036): 6.3%
• Incremental Opportunity: USD 5.06 billion
• Leading Treatment Segment: Chemotherapy (58.2% share)
• Leading Administration Route: Injectable (49.0% share)
• Fastest Growing Markets: USA and South Korea (6.4% CAGR)
Market Size and Forecast: Oncology Innovation Reshapes Pleural Disease Care
The pleural diseases therapeutics market is projected to grow from USD 6.00 billion in 2026 to USD 11.06 billion by 2036, reflecting a CAGR of 6.3%. Market expansion is being driven by increasing treatment demand for mesothelioma, malignant pleural effusion, pleurisy, and pneumothorax, alongside growing adoption of targeted biologics and minimally invasive thoracic procedures.
As healthcare systems prioritize multidisciplinary cancer management, pharmaceutical therapies, surgical procedures, and pleural drainage technologies are becoming central to hospital oncology and pulmonology infrastructure.
Key Growth Drivers: Immunotherapy, Procedural Demand, and Diagnostic Advances
1. Rising Mesothelioma Treatment Demand
Systemic chemotherapy regimens, including pemetrexed and cisplatin combinations, continue to dominate treatment protocols for malignant pleural mesothelioma. Expanding patient diagnosis rates are sustaining demand for oncology therapeutics.
2. Growth of Immuno-Oncology Therapies
Checkpoint inhibitor combinations such as nivolumab and ipilimumab are transforming first-line mesothelioma treatment. These biologic therapies are shifting market value toward high-cost targeted oncology solutions.
3. Expansion of Pleural Intervention Procedures
Thoracentesis, pleurodesis, indwelling pleural catheters, and video-assisted thoracoscopic surgery (VATS) are driving recurring demand for hospital consumables, drainage systems, and procedural devices.
Market Challenges: High Treatment Costs and Regulatory Complexity
Despite strong growth momentum, the market faces several operational and clinical barriers:
• High biologic therapy and immunotherapy costs
• Complex regulatory approval pathways for oncology drugs
• Reimbursement variability across healthcare systems
• Specialized infrastructure requirements for thoracic surgery and pleural interventions
These factors continue to shape procurement strategies and competitive positioning among global manufacturers.
Speak to Analyst: Customize insights for your business strategy:
https://www.futuremarketinsights.com/customization-available/rep-gb-16576
Segmentation Insights: Chemotherapy and Conventional Therapies Lead
By Treatment
• Chemotherapy dominates with 58.2% share in 2026
• Combination chemotherapy and systemic regimens remain first-line standards
• VATS, thoracostomy, pleurodesis, and catheter-based interventions support procedural demand
By Route of Administration
• Injectable therapies lead with 49.0% share due to intravenous chemotherapy and biologic delivery
• Intrapleural administration supports targeted pleural treatment approaches
By Technology
• Conventional therapies account for 52.0% share
• Targeted therapies and immuno-oncology segments represent the fastest-growing revenue opportunities
Regional Analysis: USA and South Korea Lead Global Growth
High-Growth Markets
• USA (6.4% CAGR): Supported by advanced oncology infrastructure and mesothelioma treatment capabilities
• South Korea (6.4% CAGR): Driven by oncology investment and clinical trial participation
• Japan (6.3% CAGR): Supported by aging demographics and thoracic surgery expertise
• EU (6.3% CAGR): Strengthened by harmonized oncology treatment frameworks
The market reflects growing global alignment toward precision oncology, advanced diagnostics, and minimally invasive pleural disease management.
Competitive Landscape: Oncology Pipelines Define Market Leadership
Competition is centered on oncology innovation, device integration, and specialist distribution capabilities.
Key players include:
• AstraZeneca plc
• Bristol-Myers Squibb
• Becton, Dickinson and Company
• Roche Holding AG (Genentech)
• Rocket Medical plc
• Novocure
• Medtronic
Leading companies are strengthening competitive positioning through biologic therapy development, thoracic device expansion, and strategic clinical collaborations.
Future Outlook: Precision Oncology Will Accelerate Market Evolution
Over the next decade, the pleural diseases therapeutics market will evolve beyond conventional chemotherapy toward integrated biologic, immunotherapy, and device-based treatment ecosystems. Advances in diagnostic imaging, biomarker testing, and minimally invasive thoracic surgery are expected to improve patient outcomes while expanding the treated population.
As healthcare systems invest in precision oncology and specialized thoracic care infrastructure, demand for advanced pleural disease therapeutics will continue to accelerate globally.
Executive Takeaways
• The market is projected to reach USD 11.06 billion by 2036
• Chemotherapy remains the leading treatment segment with 58.2% share
• Injectable therapies dominate due to biologic and intravenous oncology treatment demand
• USA and South Korea lead global growth at 6.4% CAGR
• Immuno-oncology and minimally invasive thoracic procedures are reshaping competitive dynamics
In an increasingly specialized oncology environment, pleural diseases therapeutics are becoming critical to multidisciplinary thoracic care-bridging pharmaceuticals, biologics, and procedural technologies to improve outcomes in complex pleural conditions.
Full Report for Detailed Insights:
https://www.futuremarketinsights.com/reports/pleural-diseases-therapeutics-market
Explore More Related Studies Published by FMI Research:
mRNA Vaccine Formulation Stability and Stress Test Systems Market https://www.futuremarketinsights.com/reports/mrna-vaccine-formulation-stability-and-stress-test-systems-market
Small Molecule API Market https://www.futuremarketinsights.com/reports/small-molecule-api-market
Biosimilar Monoclonal Antibody Comparability Test Platforms Market https://www.futuremarketinsights.com/reports/biosimilar-monoclonal-antibody-comparability-test-platforms-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by Fortune 500 companies. With a global presence across the U.S., UK, India, and Dubai, FMI delivers data-driven insights across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11.06 Billion Opportunity here
News-ID: 4517923 • Views: …
More Releases from Future Market Insights Inc
Air Duct Cleaning Chemicals Market Gains Momentum as Indoor Air Quality Standard …
The global air duct cleaning chemicals market is witnessing strong growth as commercial facilities, healthcare institutions, and residential property owners increasingly prioritize indoor air quality and HVAC hygiene. According to latest insights by Future Market Insights, the market is benefiting from rising awareness around respiratory health, stricter building health standards, and growing adoption of antimicrobial treatment protocols across HVAC systems. As post-pandemic facility management strategies evolve, air duct cleaning chemicals…
Aircraft Lubricant Market Powers Next-Generation Aviation Reliability: Why Synth …
The global aircraft lubricant market is entering a high-performance growth phase as commercial aviation expansion, rising flight hours, and next-generation engine technologies accelerate demand for advanced synthetic lubrication systems. According to latest insights by Future Market Insights, aviation lubricants are becoming increasingly critical in maintaining thermal stability, engine protection, and operational efficiency across commercial and defense aircraft fleets. As airlines modernize fleets and engine OEMs introduce higher-temperature architectures, lubricant innovation…
Buckwheat-Mediterranean Grain Blend Ingredients Market Transitions from Niche Gl …
The global buckwheat-Mediterranean grain blend ingredients market is evolving from a niche specialty flour category into a technically engineered ingredient ecosystem supporting clean-label reformulation, industrial bakery automation, and alternative grain innovation. As commercial food manufacturers move beyond basic gluten-free substitution toward premium sensory performance and operational consistency, standardized multi-grain blend systems are becoming increasingly important across bakery, pasta, cereal, and snack production environments. Food processors are no longer purchasing isolated…
Bypass Fat Supplement Market Transitions Toward Precision Dairy Nutrition: Why H …
The global bypass fat supplement market is evolving from a niche dairy feed additive category into a strategically important segment within performance-driven livestock nutrition and commercial dairy productivity management. As dairy operations worldwide prioritize milk yield optimization, fertility improvement, and heat stress mitigation, bypass fat supplements are increasingly being integrated into precision feeding strategies designed to improve herd profitability and operational efficiency. Commercial dairy consolidation, rising feed-performance expectations, and scalable…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
